• Tidak ada hasil yang ditemukan

DanisaDiandra 22010110130163 bab VIII

N/A
N/A
Protected

Academic year: 2017

Membagikan "DanisaDiandra 22010110130163 bab VIII"

Copied!
16
0
0

Teks penuh

(1)

DAFTAR PUSTAKA

1. Djuanda S,Sularsito SA. Dermatitis Atopik. Dalam: Djuanda A,editor. Ilmu Penyakit Kulit dan Kelamin Edisi ke- 6. Jakarta: FK UI; 2007. h.138-47.

2. Yusuf A, Sunarko M. Dermatitis Atopik di Divisi Alergi URJ Kulit Kelamin RSU

DR.Soetomo Surabaya 2003-2005. Berkala Ilmu Kesehatan Kulit dan Kelamin. Surabaya: Airlangga University Press; 2007. h. 9-25.

3. Leung DYM, Eichenfield LF, Bogunewwicz M. Atopic dermatitis (atopic eczema). Dalam:

Wolf K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffel DA, ed. Fitzpatrick’s

Dermatology in general medicine edisi ke-7. New York: Mc Graw Hill; 2008. h. 146-57.

4. Kabulrahman. Penyakit Kulit Alergi. Semarang : Fakultas Kedokteran Universitas Diponegoro; 2003. h.10-12.

5. Kariosentono H. Dermatitis Atopik (eksema). Surakarta: Lembaga Pengembangan Pendidikan (LPP) UNS dan UPT Penerbitan dan Percetakan UNS; 2006 . h. 1-28.

6. Atopic Dermatitis, Eczema, and Non Infectionus Immunodeficiency Disorders. Dalam:

William D James M, Timothy G Berger M, Dirk M Elston M, editors. Andrews' Disease of

The Skin Clinical Dermatology. Edisi ke-11. Philadelphia, USA: Saunders ELsevier; 2011.

h. 62-9.

7. Williams HC. Atopic Dermatitis. New Engand Journal of Medicine. 2005. [Internet]. [

diperbarui: 2 Juni 2005; disitasi: 14 Januari 2014 ] 352:2314-24. Terdapat pada:

htp://www.nejm.org/doi/full/10.1056/NEJMcp042803

8. Jacoeb TNA. Manifestasi klinis dermatitis atopik pada anak. Dalam: Boediardja SA, Sugito

TL, Rihatmadja R, editor. Dermatitis pada bayi dan anak. Jakarta: Fakultas Kedokteran Universitas Indonesia; 2004. h. 58-78.

9. Brahmana ARB. Gambaran Dermatitis Atopik di Poliklinik Kulit dan Kelamin RSUD

DR.Pringadi Medan Tahun 2008. Fakultas Kedokteran Universitas Sumatera Utara

[Internet]. 2010. [ Disitasi: 11 Januari 2014]; Tersedia pada:

(2)

10. Kanwar AJ, De Dipankar. Epidemiology and Clinical Features of Dermatitis Atopic in India.

India Journal of Dermatology. [Internet]. 2011; [diperbarui: 21 Oktober 2014 ; disitasi: 28

Januari 2014]; 56(5): 471–475. Terdapat

pada:Http://www.ncbi.nlm.nih.gov/pmc/articles/PMC31201

11. Kim BS. Atopic Dermatitis. Medscape. [Internet] 2014 [diperbarui: 21 Januari 2014; disitasi

28 Januari 2014]. Terdapat pada :

Http://emedicine.medscape.com/article/1049085overview#showall

12. Charman RC, William HC. Epidemiology of Atopic Dermatitis. Dalam: Leung DYM,

Bieber Thomas editors. Atopic Dermatitis. USA: Marcel Dekker; 2002. h. 21-36.

13. Burns T. Rook’s Textbook dermatology edisi ke-8. Blackwell Publishing; 2010. h. 24-40.

14. Diepgen TL. Is The Pravelence of Atopic Dermatitis Increasing?. dalam: William HC.

Atopic Dermatitis: The Epidemiology, Causes and Prevention of Atopic Eczema. UK: Cambridge University; 2000 . h. 96-112.

15. Klaus w, Dick suurmond. Flitzpatrick’s color atlas and sypnosis edisi ke-5. New York: Mc

Graw Hill; 2005. h.35-40.

16. Remitz A, Sakari Reitamo. The Clinical Manifestations of Atopic Dermatitis. dalam:

Reitamo S, Thomas A, Martin S. Text Book of Atopic Dermatitis. UK: Informa Healthcare; 2008. h.1-11.

17. Werfel T. Classification, Clinical features and Differential Diagnosis of Atopic Dermatitis.

dalam: Werfel T,W. Kiess, J. M. Spergel. Atopic Dermatitis in Childhood and Adolescence

Vol 15. Switzerland: Karger publisher; 2011. h. 2-20.

18. Brown GR, Tonny Burns. Lecture Notes On Dermatologi 8th ed. Jakarta: Penerbit Erlangga;

2005. h. 73-4 .

19. Sugito TL. Penatalaksanaan Terbaru Dermatitis Atopik. Dalam : Boediardja SA, Sugito TL, Indriatmi W, Devita M, Prihianti S,editor. Dermatitis atopik. Jakarta: Balai Penerbit FKUI;

2009. p. 39-55.

20. Hunter JAA, JA Savin, MV Dahl. Clinical Dermatology edisi ke-2. Cambridge : Blackwell

Science; 1995. h. 92-7.

21. Natalia, Sri Linuwih Menaldi, Triana Agustin. Perkembangan Terkini pada Terapi Dermattis

(3)

13 Januari 2014]; 61(7): 299-304. Tersedia pada: http:// Journal Indonesian

medical/22550/32.pdf

22. Hussain SH, James RT, Albert CY. Infantile Atopic Dermatitis. dalam: Donald Rudikoff

D,Steven RC, Noah S. Atopic Dermatitis and Eczematous Disorders. Florida: CRC Press;

2014 . h. 77-88.

23. Maibach HI. Evidence Based Dermatology edisi ke-2. California: People’s Medical

Publishing House; 2011. h. 297-325.

24. Tranggono RI, Latifah F. Buku Pegangan Ilmu Pengetahuan Kosmetik. Jakarta: Penerbit

Gramedia; 2011. h. 75-82 .

25. MA Ari. Dermatitis dan Peran Steroid Dalam Penanganannya. Dexa Media .[Internet]. 2009.

[diperbarui: 17 Oktober 2004 disitasi: 10 Juni 2014]. 17(4):1-7 . Terdapat pada: http://

unhas.ac.id / tahir / BAHAN - KULIAH/ BIO-MEDICAL/ BAHAN-UMUM /

ECHOCARDIOGRAPHY % 20 ( % 20 SALEH %20 -% 20D 411 % 2002 % 20050 % 20) /

REFERENSI / dermatitis.pdf.

26. Yanhendri. Berbagai Bentuk Sediaan Topikal Dalam Dermatologi. Kalbemed. [Internet].

2012. [diperbarui : 6 Agustus 2012 disitasi : 10 Juni 2014]. 39(6): 423-30. Terdapat pada:

http: // www.kalbemed.com /Portals /6 / 08_194Berbagai%20Bentuk %20 Sediaan % 20

Topikal%20dalam%20Dermatologi.pdf.

27. Watson Wade, Sandeep Kapur. Atopic Dermatitis. AACI J. [Internet]. 2011. [diperbarui: 20

Desember 2011 disitasi: 20 Juni 2014].7(4):1-7. Terdapat pada: http : //

www.aacijournal.com / content/7/s1/s4

28. Saeki H. Guidelines For Management Of Atopic Dermatitis. JDA J. [Internet]. 2009.

[diperbarui: 28 September 2009 disitasi: 20 Juni 2014]. 36(10):563-577. Terdapat pada: http:

// onlinelibrary .wiley.com / doi/10.1111/j.1346-8138.2009.00706.x/full#b4

29. Tomas KS. Randomised Controlled Trial of Short Bursts of a Potent Topical Corticosteroid

Versus Prolonged Use of a Mild Preparation for Children With Mild or moderate Atopic

Eczema. BMJ. [Internet]. 2002. [diperbarui: 30 Maret 2002 disitasi: 20 Juni 2014 ] 3(24):

(4)

30. William H, Kim Thomas. Atopic Dermatitis. Dalam: William H. Evidence-Based

Dermatology BMJ . London: BMJ Book; 2003.h 144-218

31. Anthony C.Antibacterial/Steroid Combination Therapy In Infected Eczema. Acta Derm

Venerol. [Internet].2008. [diperbarui: 11 Mei 2008 disitasi: 20 Juni 2014] 2(16): 28-34.

(5)
(6)

Lampiran 2

NOMOR REKAM MEDIK

(7)

frequencies

Kriteria

101 83,5 83,5 83,5

20 16,5 16,5 100,0

121 100,0 100,0

Sesuai Tidak sesuai Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Usia

25 24,8 24,8 24,8

29 28,7 28,7 53,5

47 46,5 46,5 100,0

101 100,0 100,0

0 - 2 2 - 12 > 12 Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Jenis kel amin

39 38,6 38,6 38,6

62 61,4 61,4 100,0

101 100,0 100,0

Laki-laki Perempuan Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Riwayat atopi

52 51,5 51,5 51,5

49 48,5 48,5 100,0

101 100,0 100,0

Ada Tidak ada Total Valid

Frequency Percent Valid Percent

(8)

Waj ah

28 27,7 27,7 27,7

73 72,3 72,3 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Fl exor

59 58,4 58,4 58,4

42 41,6 41,6 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Ektensor

62 61,4 61,4 61,4

39 38,6 38,6 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Anti histamin

72 71,3 71,3 71,3

29 28,7 28,7 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Steroi d_oral

12 11,9 11,9 11,9

89 88,1 88,1 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

(9)

Steroi d_topikal

77 76,2 76,2 76,2

24 23,8 23,8 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Anti biotik_oral

6 5,9 5,9 5,9

95 94,1 94,1 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Anti biotik_topikal

21 20,8 20,8 20,8

80 79,2 79,2 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Lainnya

64 63,4 63,4 63,4

37 36,6 36,6 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

CTM TAB

24 23,8 23,8 23,8

77 76,2 76,2 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

(10)

Loratadin tab

10 9,9 9,9 9,9

91 90,1 90,1 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Mebhi drolin tab (i nterhistin)

27 26,7 26,7 26,7

74 73,3 73,3 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Raniti din tab

1 1,0 1,0 1,0

100 99,0 99,0 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Loratadin syr (claritin syr)

2 2,0 2,0 2,0

99 98,0 98,0 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Cetri zine tab

9 8,9 8,9 8,9

92 91,1 91,1 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

(11)

Metil prednison tab

5 5,0 5,0 5,0

96 95,0 95,0 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Dexametason tab

1 1,0 1,0 1,0

100 99,0 99,0 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Betametason tab

2 2,0 2,0 2,0

99 98,0 98,0 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Betametason syr (cel estamin syr)

1 1,0 1,0 1,0

100 99,0 99,0 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Hidrokortison 1- 2, 5 %

13 12,9 12,9 12,9

88 87,1 87,1 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

(12)

Desonide (desolex cr)

18 17,8 17,8 17,8

83 82,2 82,2 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Desoximetasone/dexametason (i nerson oi nt)

18 17,8 17,8 17,8

83 82,2 82,2 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

dexa cream

1 1,0 1,0 1,0

100 99,0 99,0 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Betametason (di progenta,benoson, )

28 27,7 27,7 27,7

73 72,3 72,3 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Diflukortolon valerat (nerilon cr)

2 2,0 2,0 2,0

99 98,0 98,0 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

(13)

Mometasone

101 100,0 100,0 100,0

Tidak Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Clobetasol propionate

2 2,0 2,0 2,0

99 98,0 98,0 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Gentamisi n tab

2 2,0 2,0 2,0

99 98,0 98,0 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Amoksil in tab (amox tab)

4 4,0 4,0 4,0

97 96,0 96,0 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Cefadroxil tab

2 2,0 2,0 2,0

99 98,0 98,0 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

(14)

Mupi roci n (mupiroxin)

1 1,0 1,0 1,0

100 99,0 99,0 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

As. fusidat (fuson)

7 6,9 6,9 6,9

94 93,1 93,1 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Gentamisi n cr

13 12,9 12,9 12,9

88 87,1 87,1 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

fluocinolon acetonide 0,25% +gentamisi n (gentasolon cream)

2 2,0 2,0 2,0

99 98,0 98,0 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

betametason+ gentamisin (di progenta cream)

6 5,9 5,9 5,9

95 94,1 94,1 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

(15)

Pelembab

60 59,4 59,4 59,4

41 40,6 40,6 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Mosturizer lotion

40 39,6 39,6 39,6

61 60,4 60,4 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Urea cream

23 22,8 22,8 22,8

78 77,2 77,2 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

Cumulat iv e Percent

Kompres NaCl

4 4,0 4,0 4,0

97 96,0 96,0 100,0

101 100,0 100,0

Y a Tidak Total Valid

Frequency Percent Valid Percent

(16)

Identitas

Nama :Danisa Diandra Safarina

NIM :22010110130163

Tempat/Tanggal lahir : Semarang, 2 Juni 1992 Jenis kelamin :Perempuan

Alamat :JL. Singa utara no 18 Semarang No Telp :024 6709444

No HP :081326490497

Email : [email protected]

Riwayat Pendidikan

1.SD : SD H ISRIATI SEMARANG Lulus tahun: 2004

2.SMP : SMPN3 SEMARANG Lulus tahun: 2007

3.SMA : SMAN 3 SEMARANG Lulus tahun: 2010

Referensi

Dokumen terkait

Skin areas infected with atopic dermatitis also is characterized by unusual and unaesthetic skin drying.. Treating

These are ˘ Atopic Eczema (can result in scratching of skin and skin infection), Allergic Contact Dermatitis (leads to skin irritation), Irritant Contact Dermatitis (dry and

International Journal of Antimicrobial Agents Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum-lactamase-producing Escherichia coli

"Impact of change in household hygiene conditions on morbidity in India: Evidence from longitudinal survey", Clinical Epidemiology and Global.

Mousdicas finished a clinical fellowship in the Department, and is now Associate Professor of Clinical Dermatology.. Mousdicas has interest in general adult and pediatric dermatology,

R E S E A R C H A R T I C L E Effect of topical marshmallow Althaea officinalis on atopic dermatitis in children: A pilot double-blind active-controlled clinical trial of an

Quercetin Improves Inflammation, Oxidative Stress, and Impaired Wound Healing in Atopic Dermatitis Model of Human Keratinocytes.. Normal keratinization in a spontaneously immortalized

Journal of Clinical